Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin.
about
Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunityPathogenesis of rheumatoid arthritis: how early is early?Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implicationsThe inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachThe role of circulating fibrocytes in inflammation and autoimmunityEffect of IL-17 receptor A blockade with brodalumab in inflammatory diseasesMultiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapyTumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental ArthritisDetection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritisIL-15 expression on RA synovial fibroblasts promotes B cell survivalLocation of CD4+ T cell priming regulates the differentiation of Th1 and Th17 cells and their contribution to arthritis.Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recoveringComponents of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data.The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis.Linking power Doppler ultrasound to the presence of th17 cells in the rheumatoid arthritis jointHuman innate immunosenescence: causes and consequences for immunity in old age.Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis.Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritisInterferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.Fibrocyte activation in rheumatoid arthritisNatural killer cells trigger osteoclastogenesis and bone destruction in arthritis.Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis.Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritisRheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression.Tissue specific CD4+ T cell priming determines the requirement for interleukin-23 in experimental arthritisThe microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients.Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis.Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis.Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis.Anti-collagen type II antibodies in patients with very early synovitis.Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative].Peripheral CD4CD8 double positive T cells with a distinct helper cytokine profile are increased in rheumatoid arthritis.Defining immunological impact and therapeutic benefit of mild heating in a murine model of arthritisMeasurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis.A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients.Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis.Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritisIncreasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
P2860
Q22306446-98CBD058-5967-4532-9C44-E40C0C012A10Q24810459-265402F5-ADCB-4621-95E9-248FB271B3F8Q26738960-E0C4762B-053A-4587-94B7-F443C73ABAB8Q26765937-1F5F0444-23C7-493C-9476-E2F24A6CB96CQ26829700-A0ACD8FF-49BA-409D-8CB6-8E56F19D6554Q28076496-E871D112-66DA-4929-8D73-02198586A7B5Q28475972-05C548E4-FBCE-455E-9134-1BC7887EF9A6Q28552434-1BAF35BA-8508-4F13-AFE7-F8915334A0F1Q28590712-35D326B6-4DCE-436D-8D4F-C4B54B5EF808Q28727368-F63BC503-B2FB-4866-9847-70F767887E2FQ30412824-C606DA72-5BAE-43FD-9FF7-4137DE10B61DQ30415505-77BD85EA-E2B4-418D-A179-0FF26C77C36EQ31112066-09FB7796-71BC-4CBA-A0D4-41E84C9ECE73Q33669345-84A29F34-CE87-4C11-80DC-17BCCE9C9FDEQ33687116-FDCD3E75-DCB4-422D-BAEA-B9EA83576D75Q33796293-944FEAB6-1ACE-466C-BCB2-0BF3E8D30DFCQ33916589-9156C8A9-66CF-4F7D-AAEE-D0F4E0AF46FFQ33923285-1B408FCF-5DD6-41D4-9997-C9F91F351095Q33923325-DE6231A5-5239-4408-A72A-642839256293Q34019284-FF48F90A-94E0-416A-9320-B428353CE7C3Q34059280-FDFA6EE4-9D5E-4DE6-9BD6-F7562EC49729Q34081877-DEDDE381-CF2F-4B0E-9CBB-F8FC72D03462Q34237586-C8B57098-2054-415C-BF36-1E45E9F79F0AQ34274249-1611E7D8-8EA7-4566-B29A-CE1E3ABA3D84Q34346316-B4CBEFE9-A807-47E9-9908-102980BC7A81Q34375258-6AAF5A8C-70D7-4D03-8C6F-FC30F50466BBQ34544926-CE820037-448A-4751-B636-8637BC25B6B1Q34551260-CD1E3CE0-B5F8-410E-97EE-1E7D6E73CFE1Q34700316-AB391A2D-88AD-4086-902B-B2B97D2F860DQ35012157-F6D68FC4-DBD5-4057-AC23-B577C1F45152Q35058065-9FE385CC-3AF0-4870-94ED-57FBD30C54B6Q35094171-C6B0641D-5DF9-4074-A556-00EC6A8F77ACQ35109668-A075FD6E-B605-480A-A50E-BA9381E20B31Q35131197-3319CE22-AD6E-49DD-B191-DABBF81C65DFQ35202064-54BA3557-7C59-4D97-85B1-CE6603DF195AQ35211917-A53366A2-74AB-4220-A7D5-09852A913D09Q35586904-3151C7AC-DB87-400A-808D-9AD9CE9525FFQ35604590-F04C126F-70A6-40D9-ACF4-04F32A6B491DQ35605600-C5243979-3522-44CC-A3B0-5A9EB650C873Q35617683-91E94AFD-4B99-4FF5-B186-C7746F250E69
P2860
Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Early rheumatoid arthritis is ...... T cell and stromal cell origin
@nl
Early rheumatoid arthritis is ...... cell and stromal cell origin.
@ast
Early rheumatoid arthritis is ...... cell and stromal cell origin.
@en
type
label
Early rheumatoid arthritis is ...... T cell and stromal cell origin
@nl
Early rheumatoid arthritis is ...... cell and stromal cell origin.
@ast
Early rheumatoid arthritis is ...... cell and stromal cell origin.
@en
prefLabel
Early rheumatoid arthritis is ...... T cell and stromal cell origin
@nl
Early rheumatoid arthritis is ...... cell and stromal cell origin.
@ast
Early rheumatoid arthritis is ...... cell and stromal cell origin.
@en
P2093
P2860
P3181
P356
P1476
Early rheumatoid arthritis is ...... cell and stromal cell origin.
@en
P2093
Arne N Akbar
Chi-Yeung Lee
Christopher D Buckley
Emma J Ross
Francesco Falciani
Karim Raza
Mike Salmon
S John Curnow
P2860
P2888
P304
P3181
P356
10.1186/AR1733
P407
P577
2005-04-07T00:00:00Z
P5875
P6179
1048051531